MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Chikungunya: An emerging arthropod borne disease presenting as rhombencephalitis with near complete recovery

M. Shah, P. Shah, T. Singhal, K. Shetty, R. Syed, A. Aggarwal (Mumbai, India)

Meeting: 2022 International Congress

Abstract Number: 91

Keywords: Behavioral abnormalities, Brainstem reflexes, Postinfectious disorders

Category: Other

Objective: To report the clinical course and good neurological outcome of severe Chikungunya rhombencephalitis.

Background: Chikungunya is an emerging Aedes mosquito borne virus that is endemic in tropical, subtropical and increasingly temperate regions of the world. Neurological manifestations are reported in 5-10% patients, and associated with residual disability in 20% and mortality in 30%. We report potentially life-threatening rhombencephalitis, a rare complication of Chikungunya, in an adult with near-complete recovery.

Method: –

Results: A 37-year man, from Western India, endemic for dengue and Chikungunya, developed fever, joint pains, headaches, gait ataxia, dysarthria, dysphagia, followed by worsening sensorium over 10 days. On examination he had a generalized erythematous rash. There were prominent brainstem signs with roving eye movements, spontaneous decerebrate posturing, disordered breathing, spastic quadriparesis, depressed deep tendon reflexes and extensor plantar response. He had hepatosplenomegaly and pericarditis.
Brain MRI showed FLAIR hyperintensities involving brainstem, middle cerebellar peduncles and patchy subcortical white matter. The affected areas showed diffusion restriction and minimal contrast enhancement. Chikungunya IgM antibodies were present in serum. CSF showed raised proteins and pleocytosis. Febrile illnesses such as dengue, HSV, rabies, HIV, EBV, SARS-CoV-2, malaria, listeria were excluded.
Within 5 days of admission there was further neurological deterioration and he required ventilatory care. In addition to symptomatic treatment he was given IVIgG and ribavirin based on evidence from anecdotal reports. In the 3rd week of illness he developed an immune-mediated multisystemic inflammatory response syndrome that responded well to a brief course of oral steroids.
There was gradual clinical improvement, the ventilator could be weaned off at 5 weeks and the patient discharged at 8 weeks from symptom onset. At discharge he had significant bulbar dysfunction, ataxia and behavioral changes. On follow-up after 3 months, he showed near-complete neurological recovery.

Conclusion: We report the clinical course and favorable neurological outcome in a patient who presented with potentially life threatening Chikungunya rhombencephalitis. Our report highlights the potentially devastating neurological complications of Aedes borne emerging viruses such as Chikungunya, dengue and Zika.

To cite this abstract in AMA style:

M. Shah, P. Shah, T. Singhal, K. Shetty, R. Syed, A. Aggarwal. Chikungunya: An emerging arthropod borne disease presenting as rhombencephalitis with near complete recovery [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/chikungunya-an-emerging-arthropod-borne-disease-presenting-as-rhombencephalitis-with-near-complete-recovery/. Accessed July 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/chikungunya-an-emerging-arthropod-borne-disease-presenting-as-rhombencephalitis-with-near-complete-recovery/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley